Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-09 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +17,901 17,901
2025-06-04 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +44,700 44,700
2024-06-05 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +44,700 44,700
2024-01-02 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +3,051 3,051
2023-10-02 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,170 2,170
2023-07-03 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +1,743 1,743
2023-06-07 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +36,700 36,700
2023-04-03 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +1,900 1,900
2023-01-03 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +1,792 $7.19 $13K 1,792
2022-10-03 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +1,419 $9.08 $13K 1,419
2022-07-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,194 $5.87 $13K 2,194
2022-06-07 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +30,700 30,700
2022-04-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,650 $4.86 $13K 2,650
2022-01-03 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,256 $5.15 $12K 2,256
2021-10-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,463 $5.03 $12K 2,463
2021-07-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,225 $4.78 $11K 2,225
2021-04-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +2,068 $5.66 $12K 2,068
2021-03-11 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +60,000 60,000
2021-01-04 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +1,641 1,641
2020-10-01 Ros Matthew Director Grant or award · Stock Option (Right to Buy) +9,247 $1.35 $13K 9,247

Page 1 of 2 · 26 trades